Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A2585 MG-132125 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A2571 Pepstatin A9 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: aspartic proteases inhibitor -
A4002 IU11 CitationSummary: Usp14 inhibitor -
A8487 Nocodazole8 CitationTarget: Microtubules/TubulinsSummary: microtubule polymerization inhibitor -
A8627 Bafilomycin A131 CitationSummary: V-ATPases inhibitor -
A2614 Bortezomib (PS-341)52 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A4393 Paclitaxel (Taxol)28 CitationTarget: Microtubules/TubulinsSummary: microtubule depolymerization inhibitor -
A4443 Gliotoxin1 CitationTarget: 20S proteasomal chymotrypsin|Geranylgeranyltransferase I|FarnesyltransferaseSummary: 20S proteasome inhibitor -
A4429 Vialinin ATarget: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor -
A3966 Doxorubicin36 CitationSummary: DNA topoisomerase II inhibitor

